{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:17:20Z","timestamp":1788787040219,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05113-2","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:45:03Z","timestamp":1781862303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amnion-derived mesenchymal stem cells attenuate anti-GBM glomerulonephritis via regulation of neutrophil CD44 expression"],"prefix":"10.1186","volume":"17","author":[{"given":"Tomoya","family":"Nozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munetoshi","family":"Karasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Koshi-Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikao","family":"Onogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kawazoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayaho","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yamahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"5113_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"key":"5113_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137. https:\/\/doi.org\/10.1126\/science.284.5411.143.","journal-title":"Science"},{"key":"5113_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/scd.2008.0358","volume":"18","author":"S Iwashima","year":"2009","unstructured":"Iwashima S, Ozaki T, Maruyama S, Saka Y, Kobori M, Omae K, et al. Novel culture system of mesenchymal stromal cells from human subcutaneous adipose tissue. Stem Cells Dev. 2009;18:533\u201343. https:\/\/doi.org\/10.1089\/scd.2008.0358.","journal-title":"Stem Cells Dev"},{"key":"5113_CR4","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1089\/scd.2013.0016","volume":"22","author":"H Wegmeyer","year":"2013","unstructured":"Wegmeyer H, Br\u00f6ske AM, Leddin M, Kuentzer K, Nisslbeck AK, Hupfeld J, et al. Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev. 2013;22:2606\u201318. https:\/\/doi.org\/10.1089\/scd.2013.0016.","journal-title":"Stem Cells Dev"},{"key":"5113_CR5","unstructured":"Clinicaltrials.gov"},{"key":"5113_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25:829\u201348. https:\/\/doi.org\/10.3727\/096368915X689622.","journal-title":"Cell Transplant"},{"key":"5113_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2217\/17460751.4.2.275","volume":"4","author":"O Parolini","year":"2009","unstructured":"Parolini O, Soncini M, Evangelista M, Schmidt D. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med. 2009;4:275\u201391. https:\/\/doi.org\/10.2217\/17460751.4.2.275.","journal-title":"Regen Med"},{"key":"5113_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2019.101537","volume":"40","author":"L Chen","year":"2019","unstructured":"Chen L, Merkhan MM, Forsyth NR, Wu P. Chorionic and amniotic membrane-derived stem cells have distinct, and gestational diabetes mellitus independent, proliferative, differentiation, and immunomodulatory capacities. Stem Cell Res. 2019;40:101537. https:\/\/doi.org\/10.1016\/j.scr.2019.101537.","journal-title":"Stem Cell Res"},{"key":"5113_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/evj.12052","volume":"45","author":"A Lange-Consiglio","year":"2013","unstructured":"Lange-Consiglio A, Corradetti B, Meucci A, Perego R, Bizzaro D, Cremonesi F. Characteristics of equine mesenchymal stem cells derived from amnion and bone marrow: in vitro proliferative and multilineage potential assessment. Equine Vet J. 2013;45:737\u201344. https:\/\/doi.org\/10.1111\/evj.12052.","journal-title":"Equine Vet J"},{"key":"5113_CR10","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen. N Engl J Med. 2003;348:2543\u201356. https:\/\/doi.org\/10.1056\/NEJMra022296.","journal-title":"N Engl J Med"},{"key":"5113_CR11","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1046\/j.1523-1755.2003.00241.x","volume":"64","author":"CD Pusey","year":"2003","unstructured":"Pusey CD. Anti-glomerular basement membrane disease. Kidney Int. 2003;64:1535\u201350. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00241.x.","journal-title":"Kidney Int"},{"key":"5113_CR12","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","volume":"63","author":"JC Jennette","year":"2003","unstructured":"Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164\u201377. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00843.x.","journal-title":"Kidney Int"},{"key":"5113_CR13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2215\/CJN.01380217","volume":"12","author":"SP McAdoo","year":"2017","unstructured":"McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12:1162\u201372. https:\/\/doi.org\/10.2215\/CJN.01380217.","journal-title":"Clin J Am Soc Nephrol"},{"key":"5113_CR14","first-page":"199","volume":"15","author":"Y Sado","year":"1984","unstructured":"Sado Y, Okigaki T, Takamiya H, Seno S. Experimental autoimmune glomerulonephritis with pulmonary hemorrhage in rats. The dose-effect relationship of the nephritogenic antigen from bovine glomerular basement membrane. J Clin Lab Immunol. 1984;15:199\u2013204.","journal-title":"J Clin Lab Immunol"},{"key":"5113_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ki.1987.288","volume":"32","author":"WK Bolton","year":"1987","unstructured":"Bolton WK, Innes DJ Jr, Sturgill BC, Kaiser DL. T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. Kidney Int. 1987;32:869\u201376. https:\/\/doi.org\/10.1038\/ki.1987.288.","journal-title":"Kidney Int"},{"key":"5113_CR16","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1681\/ASN.2005091013","volume":"17","author":"PG Tipping","year":"2006","unstructured":"Tipping PG, Holdsworth SR. T cells in crescentic glomerulonephritis. J Am Soc Nephrol. 2006;17:1253\u201363. https:\/\/doi.org\/10.1681\/ASN.2005091013.","journal-title":"J Am Soc Nephrol"},{"key":"5113_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/ki.1989.228","volume":"36","author":"NW Boyce","year":"1989","unstructured":"Boyce NW, Holdsworth SR. Macrophage-Fc-receptor affinity: role in cellular mediation of antibody initiated glomerulonephritis. Kidney Int. 1989;36:537\u201344. https:\/\/doi.org\/10.1038\/ki.1989.228.","journal-title":"Kidney Int"},{"key":"5113_CR18","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1126\/science.279.5353.1052","volume":"279","author":"R Clynes","year":"1998","unstructured":"Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science. 1998;279:1052\u20134. https:\/\/doi.org\/10.1126\/science.279.5353.1052.","journal-title":"Science"},{"key":"5113_CR19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ki.1997.97","volume":"51","author":"S Li","year":"1997","unstructured":"Li S, Holdsworth SR, Tipping PG. Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int. 1997;51:672\u20138. https:\/\/doi.org\/10.1038\/ki.1997.97.","journal-title":"Kidney Int"},{"key":"5113_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ki.1997.12","volume":"51","author":"XR Huang","year":"1997","unstructured":"Huang XR, Tipping PG, Shuo L, Holdsworth SR. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int. 1997;51:94\u2013103. https:\/\/doi.org\/10.1038\/ki.1997.12.","journal-title":"Kidney Int"},{"key":"5113_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1681\/ASN.V132359","volume":"13","author":"J Reynolds","year":"2002","unstructured":"Reynolds J, Norgan VA, Bhambra U, Smith J, Cook HT, Pusey CD. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J Am Soc Nephrol. 2002;13:359\u201369. https:\/\/doi.org\/10.1681\/ASN.V132359.","journal-title":"J Am Soc Nephrol"},{"key":"5113_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067475","volume":"8","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Iyoda M, Shibata T, Ohtaki H, Matsumoto K, Shindo-Hirai Y, et al. Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis. PLoS ONE. 2013;8:e67475. https:\/\/doi.org\/10.1371\/journal.pone.0067475.","journal-title":"PLoS ONE"},{"key":"5113_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/sj.ki.5000083","volume":"69","author":"B Li","year":"2006","unstructured":"Li B, Morioka T, Uchiyama M, Oite T. Bone marrow cell infusion ameliorates progressive glomerulosclerosis in an experimental rat model. Kidney Int. 2006;69:323\u201330. https:\/\/doi.org\/10.1038\/sj.ki.5000083.","journal-title":"Kidney Int"},{"key":"5113_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1681\/ASN.2012030264","volume":"24","author":"K Furuhashi","year":"2013","unstructured":"Furuhashi K, Tsuboi N, Shimizu A, Katsuno T, Kim H, Saka Y, et al. Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages. J Am Soc Nephrol. 2013;24:587\u2013603. https:\/\/doi.org\/10.1681\/ASN.2012030264.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5113_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/bf03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391. https:\/\/doi.org\/10.3758\/bf03193146.","journal-title":"Behav Res Methods"},{"key":"5113_CR26","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1172\/JCI94039","volume":"127","author":"H Nishi","year":"2017","unstructured":"Nishi H, Furuhashi K, Cullere X, Saggu G, Miller MJ, Chen Y, et al. Neutrophil Fc\u03b3RIIA promotes IgG-mediated glomerular neutrophil capture via Abl\/Src kinases. J Clin Invest. 2017;127:3810\u201326. https:\/\/doi.org\/10.1172\/JCI94039.","journal-title":"J Clin Invest"},{"key":"5113_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-022-02411-3","volume":"19","author":"Y Kuramoto","year":"2022","unstructured":"Kuramoto Y, Fujita M, Takagi T, Takeda Y, Doe N, Yamahara K, et al. Early-phase administration of human amnion-derived stem cells ameliorates neurobehavioral deficits of intracerebral hemorrhage by suppressing local inflammation and apoptosis. J Neuroinflammation. 2022;19:48. https:\/\/doi.org\/10.1186\/s12974-022-02411-3.","journal-title":"J Neuroinflammation"},{"key":"5113_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088319","volume":"9","author":"K Yamahara","year":"2014","unstructured":"Yamahara K, Harada K, Ohshima M, Ishikane S, Ohnishi S, Tsuda H, et al. Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells. PLoS ONE. 2014;9:e88319. https:\/\/doi.org\/10.1371\/journal.pone.0088319.","journal-title":"PLoS ONE"},{"key":"5113_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcyt.2013.10.011","volume":"16","author":"H Kim","year":"2014","unstructured":"Kim H, Mizuno M, Furuhashi K, Katsuno T, Ozaki T, Yasuda K, et al. Rat adipose tissue-derived stem cells attenuate peritoneal injuries in rat zymosan-induced peritonitis accompanied by complement activation. Cytotherapy. 2014;16:357\u201368. https:\/\/doi.org\/10.1016\/j.jcyt.2013.10.011.","journal-title":"Cytotherapy"},{"key":"5113_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/cells8030258","volume":"8","author":"DN Silachev","year":"2019","unstructured":"Silachev DN, Goryunov KV, Shpilyuk MA, Beznoschenko OS, Morozova NY, Kraevaya EE, et al. Effect of MSCs and MSC-derived extracellular vesicles on human blood coagulation. Cells. 2019;8:258. https:\/\/doi.org\/10.3390\/cells8030258.","journal-title":"Cells"},{"key":"5113_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.molmed.2010.06.002","volume":"16","author":"TN Mayadas","year":"2010","unstructured":"Mayadas TN, Rosetti F, Ernandez T, Sethi S. Neutrophils: game changers in glomerulonephritis? Trends Mol Med. 2010;16:368\u201378. https:\/\/doi.org\/10.1016\/j.molmed.2010.06.002.","journal-title":"Trends Mol Med"},{"key":"5113_CR32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210562","volume":"219","author":"V Mysore","year":"2022","unstructured":"Mysore V, Tahir S, Furuhashi K, Arora J, Rosetti F, Cullere X, et al. Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. J Exp Med. 2022;219:e20210562. https:\/\/doi.org\/10.1084\/jem.20210562.","journal-title":"J Exp Med"},{"key":"5113_CR33","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3892\/ijmm.14.6.1035","volume":"14","author":"MB Herrera","year":"2004","unstructured":"Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004;14:1035\u201341. https:\/\/doi.org\/10.3892\/ijmm.14.6.1035.","journal-title":"Int J Mol Med"},{"key":"5113_CR34","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1681\/ASN.2007010044","volume":"18","author":"U Kunter","year":"2007","unstructured":"Kunter U, Rong S, Boor P, Eitner F, M\u00fcller-Newen G, Djuric Z, et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol. 2007;18:1754\u201364. https:\/\/doi.org\/10.1681\/ASN.2007010044.","journal-title":"J Am Soc Nephrol"},{"key":"5113_CR35","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1681\/ASN.2005080815","volume":"17","author":"U Kunter","year":"2006","unstructured":"Kunter U, Rong S, Djuric Z, Boor P, M\u00fcller-Newen G, Yu D, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol. 2006;17:2202\u201312. https:\/\/doi.org\/10.1681\/ASN.2005080815.","journal-title":"J Am Soc Nephrol"},{"key":"5113_CR36","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3727\/096368908787236567","volume":"17","author":"A Magnasco","year":"2008","unstructured":"Magnasco A, Corselli M, Bertelli R, Ibatici A, Peresi M, Gaggero G, et al. Mesenchymal stem cells protective effect in adriamycin model of nephropathy. Cell Transplant. 2008;17:1157\u201367. https:\/\/doi.org\/10.3727\/096368908787236567.","journal-title":"Cell Transplant"},{"key":"5113_CR37","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","volume":"27","author":"L Sun","year":"2009","unstructured":"Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells. 2009;27:1421\u201332. https:\/\/doi.org\/10.1002\/stem.68.","journal-title":"Stem Cells"},{"key":"5113_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/scd.2008.0092","volume":"18","author":"F T\u00f6gel","year":"2009","unstructured":"T\u00f6gel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev. 2009;18:475\u201385. https:\/\/doi.org\/10.1089\/scd.2008.0092.","journal-title":"Stem Cells Dev"},{"key":"5113_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s42003-022-03712-2","volume":"5","author":"Y Shimamura","year":"2022","unstructured":"Shimamura Y, Furuhashi K, Tanaka A, Karasawa M, Nozaki T, Komatsu S, et al. Mesenchymal stem cells exert renoprotection via extracellular vesicle-mediated modulation of M2 macrophages and spleen-kidney network. Commun Biol. 2022;5:753. https:\/\/doi.org\/10.1038\/s42003-022-03712-2.","journal-title":"Commun Biol"},{"key":"5113_CR40","doi-asserted-by":"publisher","first-page":"F1288","DOI":"10.1152\/ajprenal.00671.2009","volume":"299","author":"N Eliopoulos","year":"2010","unstructured":"Eliopoulos N, Zhao J, Bouchentouf M, Forner K, Birman E, Yuan S, et al. Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. Am J Physiol Ren Physiol. 2010;299:F1288\u201398. https:\/\/doi.org\/10.1152\/ajprenal.00671.2009.","journal-title":"Am J Physiol Ren Physiol"},{"key":"5113_CR41","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","volume":"289","author":"F T\u00f6gel","year":"2005","unstructured":"T\u00f6gel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Ren Physiol. 2005;289:F31-42. https:\/\/doi.org\/10.1152\/ajprenal.00007.2005.","journal-title":"Am J Physiol Ren Physiol"},{"key":"5113_CR42","doi-asserted-by":"publisher","first-page":"F1626","DOI":"10.1152\/ajprenal.00339.2006","volume":"292","author":"F T\u00f6gel","year":"2007","unstructured":"T\u00f6gel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Ren Physiol. 2007;292:F1626\u201335. https:\/\/doi.org\/10.1152\/ajprenal.00339.2006.","journal-title":"Am J Physiol Ren Physiol"},{"key":"5113_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1042\/CS20100147","volume":"120","author":"T Rampino","year":"2011","unstructured":"Rampino T, Gregorini M, Bedino G, Piotti G, Gabanti E, Ibatici A, et al. Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors. Clin Sci (Lond). 2011;120:25\u201336. https:\/\/doi.org\/10.1042\/CS20100147.","journal-title":"Clin Sci (Lond)"},{"key":"5113_CR44","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1681\/ASN.2006060599","volume":"17","author":"TJ Rabelink","year":"2006","unstructured":"Rabelink TJ, van Kooten C. Stem cell therapy for glomerular disease. J Am Soc Nephrol. 2006;17:2086\u20138. https:\/\/doi.org\/10.1681\/ASN.2006060599.","journal-title":"J Am Soc Nephrol"},{"key":"5113_CR45","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1681\/ASN.2004050367","volume":"16","author":"H Uchimura","year":"2005","unstructured":"Uchimura H, Marumo T, Takase O, Kawachi H, Shimizu F, Hayashi M, et al. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis. J Am Soc Nephrol. 2005;16:997\u20131004. https:\/\/doi.org\/10.1681\/ASN.2004050367.","journal-title":"J Am Soc Nephrol"},{"key":"5113_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S2221-1691(13)60045-3","volume":"3","author":"S Sakr","year":"2013","unstructured":"Sakr S, Rashed L, Zarouk W, El-Shamy R. Effect of mesenchymal stem cells on anti-Thy 1,1 induced kidney injury in albino rats. Asian Pac J Trop Biomed. 2013;3:174\u201381. https:\/\/doi.org\/10.1016\/S2221-1691(13)60045-3.","journal-title":"Asian Pac J Trop Biomed"},{"key":"5113_CR47","doi-asserted-by":"publisher","first-page":"F1004","DOI":"10.1152\/ajprenal.00587.2009","volume":"299","author":"H Tsuda","year":"2010","unstructured":"Tsuda H, Yamahara K, Ishikane S, Otani K, Nakamura A, Sawai K, et al. Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. Am J Physiol Renal Physiol. 2010;299:F1004\u201313. https:\/\/doi.org\/10.1152\/ajprenal.00587.2009.","journal-title":"Am J Physiol Renal Physiol"},{"key":"5113_CR48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tem.2022.02.002","volume":"33","author":"X Weng","year":"2022","unstructured":"Weng X, Maxwell-Warburton S, Hasib A, Ma L, Kang L. The membrane receptor CD44: novel insights into metabolism. Trends Endocrinol Metab. 2022;33:318\u201332. https:\/\/doi.org\/10.1016\/j.tem.2022.02.002.","journal-title":"Trends Endocrinol Metab"},{"key":"5113_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1053\/ajkd.2002.30563","volume":"39","author":"S Florquin","year":"2002","unstructured":"Florquin S, Nunziata R, Claessen N, van den Berg FM, Pals ST, Weening JJ. CD44 expression in IgA nephropathy. Am J Kidney Dis. 2002;39:407\u201314. https:\/\/doi.org\/10.1053\/ajkd.2002.30563.","journal-title":"Am J Kidney Dis"},{"key":"5113_CR50","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10157-015-1222-z","volume":"20","author":"S Kim","year":"2016","unstructured":"Kim S, Kim YH, Choi KH, Jeong HJ. Glomerular epithelial CD44 expression and segmental sclerosis in IgA nephropathy. Clin Exp Nephrol. 2016;20:871\u20137. https:\/\/doi.org\/10.1007\/s10157-015-1222-z.","journal-title":"Clin Exp Nephrol"},{"key":"5113_CR51","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00467-017-3775-4","volume":"32","author":"BP Froes","year":"2017","unstructured":"Froes BP, de Almeida Ara\u00fajo S, Bambirra EA, Oliveira EA, Sim\u00f5es e Silva AC, Pinheiro SVB. Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis? Pediatr Nephrol. 2017;32:2165\u20139. https:\/\/doi.org\/10.1007\/s00467-017-3775-4.","journal-title":"Pediatr Nephrol."},{"key":"5113_CR52","doi-asserted-by":"publisher","first-page":"1443153","DOI":"10.3389\/fimmu.2024.1443153","volume":"15","author":"CCY Wong","year":"2024","unstructured":"Wong CCY, Gao LY, Xu Y, Chau MKM, Zhang D, Yap DYH, et al. Cluster of differentiation-44 as a novel biomarker of lupus nephritis and its role in kidney inflammation and fibrosis. Front Immunol. 2024;15:1443153. https:\/\/doi.org\/10.3389\/fimmu.2024.1443153.","journal-title":"Front Immunol"},{"key":"5113_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1365-2249.1997.d01-977.x","volume":"108","author":"Z Jun","year":"1997","unstructured":"Jun Z, Hill PA, Lan HY, Foti R, Mu W, Atkins RC, et al. CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin Exp Immunol. 1997;108:69\u201377. https:\/\/doi.org\/10.1046\/j.1365-2249.1997.d01-977.x.","journal-title":"Clin Exp Immunol"},{"key":"5113_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif. 2020;53:e12712. https:\/\/doi.org\/10.1111\/cpr.12712.","journal-title":"Cell Prolif"},{"key":"5113_CR55","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4252\/wjsc.v8.i9.268","volume":"8","author":"OK Ma","year":"2016","unstructured":"Ma OK, Chan KH. Immunomodulation by mesenchymal stem cells: Interplay between mesenchymal stem cells and regulatory lymphocytes. World J Stem Cells. 2016;8:268\u201378. https:\/\/doi.org\/10.4252\/wjsc.v8.i9.268.","journal-title":"World J Stem Cells"},{"key":"5113_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fimmu.2012.00126","volume":"3","author":"AU Engela","year":"2012","unstructured":"Engela AU, Baan CC, Dor FJ, Weimar W, Hoogduijn MJ. On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation. Front Immunol. 2012;3:126. https:\/\/doi.org\/10.3389\/fimmu.2012.00126.","journal-title":"Front Immunol"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05113-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:03:35Z","timestamp":1788786215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05113-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5113"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05113-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental protocols were conducted in accordance with the guidelines of the Institutional Animal Ethics Committee of Nagoya University Graduate School of Medicine, and were performed under the approved project titled \u201cAmnion-derived cell therapy for kidney injury and autoimmune diseases in rats and mice\u201d (Approval number: M230165, Date of approval: March 6, 2023). Written informed consent was obtained from all participants or their legally authorized representatives for the use of AMSCs. The study was approved by the Ethics Committee of Hyogo College of Medicine (Approval number: 0325, Date of approval: August 7, 2024) for the project titled \u201cPreclinical study for development of therapies using human fetal-derived hematopoietic and mesenchymal stem cells.\u201d","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"303"}}